Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (17,194,325)	$ (11,279,158)
Acquired in-process research and development	0	500,000
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	820,814	732,803
Depreciation and amortization expense	9,476	6,074
Reduction in the carrying amount of operating lease right-of-use asset	51,967	56,736
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	1,062,681	(891,912)
Other assets	32,750	(39,313)
Accounts payable	891,478	(229,228)
Accrued expenses and other current liabilities	559,791	1,576,728
Operating lease liability	(55,078)	(52,291)
Cash used in operating activities	(13,820,446)	(9,619,561)
Cash flows from investing activities:
Acquired in-process research and development	0	(500,000)
Purchase of property and equipment	0	(36,836)
Cash used in investing activities	0	(536,836)
Cash flows from financing activities:
Cash used in financing activities	0	(102,071)
Net decrease in cash, cash equivalents and restricted cash	(13,820,446)	(10,258,468)
Cash, cash equivalents and restricted cash at beginning of period	35,497,445	49,685,586
Cash and cash equivalents at end of period	21,676,999	39,427,118
Supplemental disclosure of non-cash activities:
Right-of-use asset obtained in exchange for lease obligation	0	130,488
Private Placement
Cash flows from financing activities:
Payments for offering costs related to the private placement sale of common stock	0	(102,071)
Issued for services
Supplemental disclosure of non-cash activities:
Issuance of warrants for services provided	$ 0	$ 345,530